Stay updated with breaking news from Seqone Genomics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A seasoned leader in the pharmaceutical and diagnostics industry, specialized in structuring international healthcare sales joins the team to accelerate international expansion SeqOne Genomics,
Regulatory News: Mauna Kea Technologies (Euronext: MKEA) (Paris:MKEA) (OTCQX:MKEAY), inventor of Cellvizio, the multi-disciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform
/PRNewswire/ -- The AI in genomics market is expected to reach $19,596.2 million by 2030 from an estimated $519.0 million in 2021, at a CAGR of 49.7% from 2021...
/PRNewswire/ -- The AI in genomics market is expected to reach $19,596.2 million by 2030 from an estimated $519.0 million in 2021, at a CAGR of 49.7% from 2021...
The company plans to use the funds to focus on the oncology space.